180 related articles for article (PubMed ID: 36661029)
1. Synthesis and structure-activity relationships of pyrazole-based inhibitors of meprin α and β.
Tan K; Jäger C; Geissler S; Schlenzig D; Buchholz M; Ramsbeck D
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2165648. PubMed ID: 36661029
[TBL] [Abstract][Full Text] [Related]
2. Heteroaromatic Inhibitors of the Astacin Proteinases Meprin α, Meprin β and Ovastacin Discovered by a Scaffold-Hopping Approach.
Tan K; Jäger C; Körschgen H; Geissler S; Schlenzig D; Buchholz M; Stöcker W; Ramsbeck D
ChemMedChem; 2021 Mar; 16(6):976-988. PubMed ID: 33369214
[TBL] [Abstract][Full Text] [Related]
3. Tertiary-Amine-Based Inhibitors of the Astacin Protease Meprin α.
Tan K; Jäger C; Schlenzig D; Schilling S; Buchholz M; Ramsbeck D
ChemMedChem; 2018 Aug; 13(16):1619-1624. PubMed ID: 29927060
[TBL] [Abstract][Full Text] [Related]
4. Structure-Guided Design, Synthesis, and Characterization of Next-Generation Meprin β Inhibitors.
Ramsbeck D; Hamann A; Richter G; Schlenzig D; Geissler S; Nykiel V; Cynis H; Schilling S; Buchholz M
J Med Chem; 2018 May; 61(10):4578-4592. PubMed ID: 29694039
[TBL] [Abstract][Full Text] [Related]
5. First insight into structure-activity relationships of selective meprin β inhibitors.
Ramsbeck D; Hamann A; Schlenzig D; Schilling S; Buchholz M
Bioorg Med Chem Lett; 2017 Jun; 27(11):2428-2431. PubMed ID: 28408220
[TBL] [Abstract][Full Text] [Related]
6. The metalloproteases meprin α and meprin β: unique enzymes in inflammation, neurodegeneration, cancer and fibrosis.
Broder C; Becker-Pauly C
Biochem J; 2013 Mar; 450(2):253-64. PubMed ID: 23410038
[TBL] [Abstract][Full Text] [Related]
7. Development of high throughput screening assays and pilot screen for inhibitors of metalloproteases meprin α and β.
Madoux F; Tredup C; Spicer TP; Scampavia L; Chase PS; Hodder PS; Fields GB; Becker-Pauly C; Minond D
Biopolymers; 2014 Sep; 102(5):396-406. PubMed ID: 25048711
[TBL] [Abstract][Full Text] [Related]
8. Meprin β metalloproteases associated with differential metabolite profiles in the plasma and urine of mice with type 1 diabetes and diabetic nephropathy.
Gooding J; Cao L; Whitaker C; Mwiza JM; Fernander M; Ahmed F; Acuff Z; McRitchie S; Sumner S; Ongeri EM
BMC Nephrol; 2019 Apr; 20(1):141. PubMed ID: 31023251
[TBL] [Abstract][Full Text] [Related]
9. The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin β and ADAM10.
Jefferson T; Auf dem Keller U; Bellac C; Metz VV; Broder C; Hedrich J; Ohler A; Maier W; Magdolen V; Sterchi E; Bond JS; Jayakumar A; Traupe H; Chalaris A; Rose-John S; Pietrzik CU; Postina R; Overall CM; Becker-Pauly C
Cell Mol Life Sci; 2013 Jan; 70(2):309-33. PubMed ID: 22940918
[TBL] [Abstract][Full Text] [Related]
10. Structure and Dynamics of Meprin β in Complex with a Hydroxamate-Based Inhibitor.
Linnert M; Fritz C; Jäger C; Schlenzig D; Ramsbeck D; Kleinschmidt M; Wermann M; Demuth HU; Parthier C; Schilling S
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073350
[TBL] [Abstract][Full Text] [Related]
11. Insights from Analysis of Binding Sites of Human Meprins: Screening of Inhibitors by Molecular Dynamics Simulation Study.
Chaudhuri A; Bera AK; Sarkar I; Chakraborty S
Comb Chem High Throughput Screen; 2016; 19(3):246-58. PubMed ID: 26875789
[TBL] [Abstract][Full Text] [Related]
12. Fetuin-A and cystatin C are endogenous inhibitors of human meprin metalloproteases.
Hedrich J; Lottaz D; Meyer K; Yiallouros I; Jahnen-Dechent W; Stöcker W; Becker-Pauly C
Biochemistry; 2010 Oct; 49(39):8599-607. PubMed ID: 20806899
[TBL] [Abstract][Full Text] [Related]
13. Proteolytic processing of galectin-3 by meprin metalloproteases is crucial for host-microbiome homeostasis.
Bülck C; Nyström EEL; Koudelka T; Mannbar-Frahm M; Andresen G; Radhouani M; Tran F; Scharfenberg F; Schrell F; Armbrust F; Dahlke E; Zhao B; Vervaeke A; Theilig F; Rosenstiel P; Starkl P; Rosshart SP; Fickenscher H; Tholey A; Hansson GC; Becker-Pauly C
Sci Adv; 2023 Mar; 9(13):eadf4055. PubMed ID: 37000885
[TBL] [Abstract][Full Text] [Related]
14. Role of meprin metalloproteinases in cytokine processing and inflammation.
Herzog C; Haun RS; Kaushal GP
Cytokine; 2019 Feb; 114():18-25. PubMed ID: 30580156
[TBL] [Abstract][Full Text] [Related]
15. Let it flow: Morpholino knockdown in zebrafish embryos reveals a pro-angiogenic effect of the metalloprotease meprin alpha2.
Schütte A; Hedrich J; Stöcker W; Becker-Pauly C
PLoS One; 2010 Jan; 5(1):e8835. PubMed ID: 20098618
[TBL] [Abstract][Full Text] [Related]
16. Human meprin alpha and beta homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors.
Kruse MN; Becker C; Lottaz D; Köhler D; Yiallouros I; Krell HW; Sterchi EE; Stöcker W
Biochem J; 2004 Mar; 378(Pt 2):383-9. PubMed ID: 14594449
[TBL] [Abstract][Full Text] [Related]
17. Meprin metalloproteases: Molecular regulation and function in inflammation and fibrosis.
Arnold P; Otte A; Becker-Pauly C
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt B):2096-2104. PubMed ID: 28502593
[TBL] [Abstract][Full Text] [Related]
18. Mapping orphan proteases by proteomics: meprin metalloproteases deciphered as potential therapeutic targets.
Becker-Pauly C; Broder C; Prox J; Koudelka T; Tholey A
Proteomics Clin Appl; 2014 Jun; 8(5-6):382-8. PubMed ID: 24470335
[TBL] [Abstract][Full Text] [Related]
19. Analyzing the protease web in skin: meprin metalloproteases are activated specifically by KLK4, 5 and 8 vice versa leading to processing of proKLK7 thereby triggering its activation.
Ohler A; Debela M; Wagner S; Magdolen V; Becker-Pauly C
Biol Chem; 2010 Apr; 391(4):455-60. PubMed ID: 20128684
[TBL] [Abstract][Full Text] [Related]
20. Shedding light on designing potential meprin β inhibitors through ligand-based robust validated computational approaches: A proposal to chemists!
Adhikari N; Amin SA; Ghosh B; Jha T
J Biomol Struct Dyn; 2018 Aug; 36(11):3003-3022. PubMed ID: 28862075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
